Solution for injection, for the exclusive medical use, through protocol intradermotherapy district (mesotherpy) or transdermal delivery medical care. Alidya is a complex solution specifically designed for repristinare paraphysiological and physiological changes related to the genesis and the evolution of gynoid lipodystrophy (cellulite). Developed by Prof. Pasquale Motolese and patented worldwide and registered as a medical device class III at the Italian National Institute of Health (CE0373). INDICATIONS: Treatment of gynoid lipodystrophy (cellulite), post liposuction, post intralipotherapy, lipoedema with or without lymphedema, changes in subcutaneous adipose tissue.


AlidyaTM is the first injection device specifically indicated for the prevention and treatment of gynoid lipodystrophy (cellulitis).

The action of AlidyaTM are performed using solubilization, and therefore the removal of these extracellular toxic elements, as well as the restoration of normal cell homeostasis, which is clinically translated by an improvement of areas suffering from or predisposed to development of cellulite.